v3.25.4
SHARE-BASED COMPENSATION PLANS (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense and Income Tax Benefits Recognized
The following table provides information on Share-based compensation expense and related income tax benefits recognized:
(In millions)
202520242023
Unvested stock awards$36 $40 $42 
Stock option and employee stock purchase plans3 2 2 
Share-based compensation expense39 42 44 
Income tax benefit(4)(5)(6)
Share-based compensation expense, net of tax
$35 $37 $38 
Schedule of Nonvested Stock Awards
The following is a summary of activity for RSUs as of and for the year ended December 31, 2025:

 
Time-Vested (1)
Performance-Based (2)
(Shares in millions)
SharesWeighted-
Average
Grant Date
Fair Value		SharesWeighted-
Average
Grant Date
Fair Value
Unvested stock awards at January 1, 2025
0.6$86.37 0.4$97.81 
Granted0.2156.86 0.1163.93 
Vested (0.2)89.59 (0.2)76.68 
Unvested stock awards at December 31, 2025
0.6$103.07 0.3$126.49 
_____________ 
(1)    Includes RSUs granted to non-executive members of the board of directors.
(2)    Initially granted at target, assuming 100% payout.
Schedule of Stock Option Awards The following table summarizes the activity related to our stock option awards:
(Option awards and aggregate intrinsic value in millions)
Number of Option Awards
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining Contractual Term (Years)
Aggregate Intrinsic Value (1)
Outstanding and exercisable as of December 31, 2024
0.7$67.33 2.5$58 
Exercised(0.2)$58.06 —$20 
Outstanding and exercisable as of December 31, 2025
0.5$70.72 2.0$57 
_____________ 
(1)    The intrinsic value represents the amount by which the fair value of our stock price exceeds the option exercise price, multiplied by the number of in-the-money options.
Schedule of Share Purchase and Related Weighted-Average Exercise Price
The following table presents the shares purchased and the related weighted-average purchase price under the ESPP:
2025 (1)
20242023
Shares purchased107,000 120,000 152,000 
Weighted average purchase price$143.41 $114.84 $82.81 
_____________ 
(1)    As of December 31, 2025, there were 7.5 million shares authorized for issuance and 1.3 million shares remaining available to be purchased in the future.